Clinical Study to Evaluate Remineralization Using an in Situ Model.
← catalyst calendarNCT07625670 · readout ≤ 73 d
Sponsored by Colgate Palmolive (industry) · CL — their whole pipeline →. With Federal University of Paraíba.
Phase
Phase 3
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · Quadruple · Other
Enrollment
30estimated
Sites
1
Country
Brazil
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jun 2026 | estimated | When the study began enrolling |
| Primary completion | Oct 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Oct 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2026-06-04 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-04 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Remineralization
- Enamel Lesions
- Enamel Subsurface Lesion
Interventions
- Drug: Fluoride toothpaste containing 750 ppm MFP in a Dical base
- Drug: Fluoride toothpaste containing 1450 ppm MFP in a Dical base
- Drug: Fluoride-free toothpaste in a Dical base
- Device: Toothbrush
Primary outcome
what the primary-completion date above is the date OFChange in integrated mineral loss (Δz)
measured 9 weeks
Permalink · CL's whole pipeline · Catalyst calendar · Every registered study · What changed